Healthcare analytics company MultiPlan has rebranded and changed its name to Claritev.
The company, which spent much of the past year navigating rising debt and antitrust lawsuits, said Tuesday the rebrand will have no affect on its existing services. It also plans to begin trading on the New York Stock Exchange under the ticker CTEV on Feb. 28.
Related: MultiPlan, insurers file motion to dismiss antitrust lawsuit
"Today’s announcement opens a new chapter for Claritev as we accelerate the use of innovation and technology to better serve our core clients and the broader healthcare ecosystem," President and CEO Travis Dalton said in a Tuesday news release. "By embracing technology modernization, data infrastructure, cutting edge tools like AI and scale partners, we believe we will be best positioned against the competition. ...This will allow us to deepen our line of products that deliver transparent and fair data insights and make healthcare more affordable for all.”
Claritev did not immediately respond to a request for comment.
In December, the company reached an agreement with its creditors to extend the maturities of its existing debt, which was reported to be $4.5 billion as of Sept. 30.
Claritev has also faced a number of antitrust lawsuits over the past alleging it colluded with insurers to reduce pay for out-of-network providers. The company denies the allegations.
"We have consistently stated that these lawsuits are without merit and would ultimately increase prices for patients and employers,” a spokesperson told Modern Healthcare in November.
The company, along with several large insurers, filed a motion in January to dismiss one lawsuit filed by the American Medical Association and numerous healthcare providers. Claritev argues that the suit should be thrown out because a market for out-of-network services among payers does not exist.
